Latest Breaking News On - International bladder cancer group - Page 4 : comparemela.com

Scoring System Predicts TURBT Risk in NMIBC Active Surveillance Cases

Emerging data suggest that active surveillance is a safe option in select patients with NMIBC. Among patients with low-grade nonmuscle-invasive bladder cancer (NMIBC) on active surveillance, a tool can predict the future risk of undergoing TURBT.

United statesShilajitd kunduDanielr greenbergAshishm kamatInternational bladder cancer groupNorthwestern university feinberg school of medicineUniversity of texas md anderson cancer centerCancer centerNorthwestern university feinberg school

Scoring System Predicts TURBT Risk in NMIBC Active Surveillance Cases

Emerging data suggest that active surveillance is a safe option in select patients with NMIBC. Among patients with low-grade nonmuscle-invasive bladder cancer (NMIBC) on active surveillance, a tool can predict the future risk of undergoing TURBT.

United statesDanielr greenbergShilajitd kunduAshishm kamatInternational bladder cancer groupUniversity of texas md anderson cancer centerNorthwestern university feinberg school of medicineCancer centerNorthwestern university feinberg school

Theralase Technologies Inc : Theralase Releases Corrected and Restated Press Release for 1Q2023 Interim Financial Statements

In the Performance to Primary, Secondary and Tertiary Objectives second table the 90 day results were misstated and has been corrected in this press release.TORONTO, ON / ACCESSWIRE / May 30, 2023 / Theralase®

United statesSan franciscoRoger dumoulin whiteArkady mandelRegulation services providerVenture exchangeAmerican urology associationClean technologyLife sciencesCompany annual meeting onCompany photo dynamic compoundsOntario securities commissionInternational bladder cancer groupDevelopment expensesToronto stock venture exchangeTechnologies inc

Theralase Technologies Inc : Theralase Releases 1Q2023 Interim Financial Statements

TORONTO, ON / ACCESSWIRE / May 30 2023 / Theralase® Technologies Inc. ("Theralase" or the "Company") (TSXV:TLT)(OTCQB:TLTFF), a clinical stage pharmaceutical company dedicated to the research and development

United statesSan franciscoRoger dumoulin whiteArkady mandelClean technologyAmerican urology associationCompany photo dynamic compoundsTheralase technologies incCompany antiVenture exchangeRegulation services providerTechnologies incCompany board of directorsTheralase technologies inc viewInternational bladder cancer groupAmerican society of clinical oncology

Theralase(R) Releases Corrected and Restated Press Release for 1Q2023 Interim Financial Statements

Theralase(R) Releases Corrected and Restated Press Release for 1Q2023 Interim Financial Statements
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

San franciscoUnited statesRoger dumoulin whiteArkady mandelCompany antiClean technologyOntario securities commissionTechnologies incVenture exchangeAmerican urology associationRegulation services providerToronto stock venture exchangeCompany board of directorsToronto stock exchange ventureTheralase technologies incInternational bladder cancer group